The facility - which is at a site on Jurong, an artificial island off the southwest of the main island of Singapore – will produce 70,000 metric tons of pharmaceutical-grade sodium bicarbonate a year.
Manufacturing will adhere to principles and technology developed by Novacap’s subsidiary Novacarb at its facility in Nancy, France.
The approach - developed by Novacarb as part of its €15m "Bianca" project - combines manufacturing technologies and worker training.
The Singapore facility will be operated by Novabay Pte Ltd and is scheduled to begin production activities in the second quarter of 2017.
Novabay Pte president, Raymond Sinnah, said: “This will enable us to offer high-quality grades and a strong alternative of Sodium Bicarbonate supply in Asia. Singapore is a perfect location and logistic hub to capture the growth and to efficiently serve our customers and targeted markets."